NxGen MDx

NxGen MDx provides commercial clinical laboratory services focused on high-quality genetic carrier screening, non-invasive prenatal screening using whole-genome sequencing technology, hereditary cancer risk panels covering NCCN-recommended genes, comprehensive pathogen testing for urogenital infections including vaginosis/UTI panels with rapid turnaround times, and respiratory pathogen panels. Their tests are widely used in women’s health settings to inform reproductive decision-making or guide treatment of infectious diseases. The company emphasizes accuracy (>99% detection rate for many conditions), inclusivity across ethnicities/populations in their screens, actionable results for clinicians/patients, and access to board-certified genetic counselors.